Nov. 30, 2025 — GE HealthCare has announced the 510(k) submissions to the U.S. Food and Drug Administration (FDA) seeking clearance for next-generation SIGNA MRI technology. Unveiled at RSNA 2025, these differentiated solutions are part of a wave of new GE HealthCare innovations aimed at tackling complex healthcare challenges.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now